Immune Response News and Research

RSS

Scientists get inside look at how AIDS virus grooms its assault team

A new study by Los Alamos National Laboratory and University of Pennsylvania scientists defines previously unknown properties of transmitted HIV-1, the virus that causes AIDS.

2 Apr 2013

Researchers use common virus to modify adult stem cells

Using the same strategy that a common virus employs to evade the human immune system, researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine have modified adult stem cells to increase their survival - with the goal of giving the cells time to exert their natural healing abilities.

2 Apr 2013

Research findings could lead to new targets for treating inflammatory disorders

Researchers at UC Davis have shown how the innate immune system distinguishes between dangerous pathogens and friendly microbes. Like burglars entering a house, hostile bacteria give themselves away by breaking into cells. However, sensing proteins instantly detect the invasion, triggering an alarm that mobilizes the innate immune response.

2 Apr 2013

Research findings could improve treatments for pneumonia, other inflammatory conditions

Scientists at the University of Pittsburgh School of Medicine have discovered a new biological pathway of innate immunity that ramps up inflammation and then identified agents that can block it, leading to increased survival and improved lung function in animal models of pneumonia.

1 Apr 2013

Research roundup: Despite some cuts, hospitals will benefit from Medicaid expansion; Medicare's rising costs propel efforts to revamp the program

The authors write that, because of the health law's expansion of Medicaid coverage to adults making below 138 percent of the federal poverty level, "hospitals' public insurance revenue [will create] a larger Medicaid coverage pool.

30 Mar 2013

Report finds most restaurant children's meals are still unhealthy

Many menu items don't meet the restaurant association's own standards for healthful children's meals, the New York Times reports.

30 Mar 2013

First Edition: March 29, 2013

Today's early morning highlights from the major news organizations, including coverage of renewed interest between President Barack Obama and congressional Republicans to find ways to cut Medicare costs:

29 Mar 2013

MD Anderson researchers named Fellows to new AACR academy

Five researchers and leaders from The University of Texas MD Anderson Cancer Center have been named Fellows to a new academy launched by the world's oldest and largest organization dedicated to cancer research, the American Association for Cancer Research.

29 Mar 2013

CureVac begins CV9104 Phase 2b clinical trial in patients with castration-resistant prostate cancer

CureVac GmbH, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA, today announced that it has initiated a double-blind, randomized Phase 2b clinical trial of its RNActive cancer vaccine, CV9104, for the treatment of patients with castration-resistant prostate cancer.

28 Mar 2013

FDA accepts Merck's BLA for investigational Timothy grass pollen AIT

Merck, known as MSD outside the United States and Canada, today announced that the Biologics License Application for its investigational Timothy grass pollen (Phleum pratense) allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration.

28 Mar 2013

Novel molecular mechanism can prevent aging and cancer progression, say researchers

University of Montreal researchers have discovered a novel molecular mechanism that can potentially slows the aging process and may prevent the progression of some cancers.

27 Mar 2013

Penn researchers develop nanotechnology-inspired technique for diagnosing Lyme disease

Early diagnosis is critical in treating Lyme disease. However, nearly one quarter of Lyme disease patients are initially misdiagnosed because currently available serological tests have poor sensitivity and specificity during the early stages of infection.

27 Mar 2013

Study provides important insight into how BMT treatment works in patients with MS

A new study by Multiple Sclerosis researchers at three leading Canadian centres addresses why bone marrow transplantation has positive results in patients with particularly aggressive forms of MS.

27 Mar 2013

New vaccine proves highly effective against H5N1 virus

Until now most experimental vaccines against the highly lethal H5N1 avian influenza virus have lacked effectiveness. But a new vaccine has proven highly effective against the virus when tested in both mice and ferrets. It is also effective against the H9 subtype of avian influenza.

26 Mar 2013

Novel cell therapy effective in treating aggressive form of childhood leukemia

Two children with an aggressive form of childhood leukemia had a complete remission of their disease—showing no evidence of cancer cells in their bodies—after treatment with a novel cell therapy that reprogrammed their immune cells to rapidly multiply and destroy leukemia cells.

26 Mar 2013

Study shows certain T cells are stimulated to provide protective antibody responses with flu vaccines

Collaborating scientists from Nationwide Children's Hospital, Baylor Institute for Immunology Research, and Mount Sinai School of Medicine have identified an important mechanism for stimulating protective immune responses following seasonal influenza vaccinations.

25 Mar 2013

Immune Response News and Research

Scientists get inside look at how AIDS virus grooms its assault team

Researchers use common virus to modify adult stem cells

Research findings could lead to new targets for treating inflammatory disorders

Research findings could improve treatments for pneumonia, other inflammatory conditions

Research roundup: Despite some cuts, hospitals will benefit from Medicaid expansion; Medicare's rising costs propel efforts to revamp the program

Report finds most restaurant children's meals are still unhealthy

First Edition: March 29, 2013

MD Anderson researchers named Fellows to new AACR academy

CureVac begins CV9104 Phase 2b clinical trial in patients with castration-resistant prostate cancer

FDA accepts Merck's BLA for investigational Timothy grass pollen AIT

Novel molecular mechanism can prevent aging and cancer progression, say researchers

Penn researchers develop nanotechnology-inspired technique for diagnosing Lyme disease

Study provides important insight into how BMT treatment works in patients with MS

New vaccine proves highly effective against H5N1 virus

Novel cell therapy effective in treating aggressive form of childhood leukemia

Study shows certain T cells are stimulated to provide protective antibody responses with flu vaccines

Study of genetically modified immune cells could help improve promising treatment for melanoma

Researchers develop new approach for HIV vaccine development

By charting differing fates of individual T cells, researchers show unpredictable aspects of immune response

Nanomedicines prevent tissue damage associated with atherosclerosis, other chronic diseases

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News